Muscle loss during GLP-1 therapy sparked a lively debate at the 2026 ADA Scientific Sessions. Here’s what the data show, who’s at risk, and how to counsel patients.
Medscape Medical News
Source link
Muscle loss during GLP-1 therapy sparked a lively debate at the 2026 ADA Scientific Sessions. Here’s what the data show, who’s at risk, and how to counsel patients.
Medscape Medical News
Source link